D.E. Shaw & Co’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-44,442
| Closed | -$1.82M | – | 3583 |
|
|
2024
Q2 | $1.82M | Sell |
44,442
-377,573
| -89% | -$15.4M | ﹤0.01% | 1855 |
|
|
2024
Q1 | $17.8M | Buy |
+422,015
| New | +$17.8M | 0.02% | 635 |
|
|
2022
Q1 | – | Sell |
-8,700
| Closed | -$282K | – | 4564 |
|
|
2021
Q4 | $282K | Sell |
8,700
-14,881
| -63% | -$482K | ﹤0.01% | 3341 |
|
|
2021
Q3 | $696K | Buy |
+23,581
| New | +$696K | ﹤0.01% | 2678 |
|